298 related articles for article (PubMed ID: 30063126)
1. Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation.
Dong H; Wang W; Mo S; Liu Q; Chen X; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J; Hu J
J Cell Mol Med; 2018 Oct; 22(10):4935-4947. PubMed ID: 30063126
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG14 promotes hepatocellular carcinoma progression via H3K27 acetylation activated PABPC1 by PTEN signaling.
Zhang H; Xu HB; Kurban E; Luo HW
Cell Death Dis; 2020 Aug; 11(8):646. PubMed ID: 32811821
[TBL] [Abstract][Full Text] [Related]
3. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract][Full Text] [Related]
4. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
[TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer.
Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J
Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PRBC induces autophagy to promote breast cancer progression through modulating PABPC1-mediated mRNA stabilization.
Liang Y; Chen B; Xu F; Long L; Ye F; Wang Y; Luo D; Li Y; Zhao W; Wang L; Jin Y; Wang L; Kong X; Su P; Yang Q
Oncogene; 2024 Mar; 43(14):1019-1032. PubMed ID: 38366145
[TBL] [Abstract][Full Text] [Related]
7. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer.
Sun Z; Zhang C; Wang T; Shi P; Tian X; Guo Y
J Cancer Res Ther; 2019; 15(4):933-940. PubMed ID: 31436255
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1.
Zhu HY; Bai WD; Ye XM; Yang AG; Jia LT
Biochem Biophys Res Commun; 2018 Feb; 496(4):1308-1313. PubMed ID: 29408336
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer.
Li W; Zhai L; Wang H; Liu C; Zhang J; Chen W; Wei Q
Oncotarget; 2016 May; 7(19):27778-86. PubMed ID: 27034004
[TBL] [Abstract][Full Text] [Related]
10. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
Zheng Z; Chen M; Xing P; Yan X; Xie B
Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
[TBL] [Abstract][Full Text] [Related]
12. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.
Baldassarre T; Truesdell P; Craig AW
Breast Cancer Res; 2017 Oct; 19(1):110. PubMed ID: 28974266
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ
Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SNHG14 contributes to gastric cancer development through targeting miR-145/SOX9 axis.
Liu Z; Yan Y; Cao S; Chen Y
J Cell Biochem; 2018 Aug; 119(8):6905-6913. PubMed ID: 29667771
[TBL] [Abstract][Full Text] [Related]
15. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
Jiao P; Hou J; Yao M; Wu J; Ren G
Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
[TBL] [Abstract][Full Text] [Related]
16. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis.
Dong H; Yang C; Chen X; Sun H; He X; Wang W
Breast Cancer; 2023 Nov; 30(6):1028-1040. PubMed ID: 37653187
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA SNHG14 enhances migration and invasion of ovarian cancer by upregulating DGCR8.
Zhao JL; Wang CL; Liu YL; Zhang GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10226-10233. PubMed ID: 31841176
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG14 accelerates breast cancer progression through sponging miR-543 and regulating KLF7 expression.
Zhang D; Ding X; Peng M
Arch Gynecol Obstet; 2022 Jun; 305(6):1507-1516. PubMed ID: 34783894
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG14 promotes osteosarcoma progression via miR-433-3p/FBXO22 axis.
Hou XK; Mao JS
Biochem Biophys Res Commun; 2020 Mar; 523(3):766-772. PubMed ID: 31948764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
